As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...